Organogenesis Inc.

NASDAQ: ORGO · Real-Time Price · USD
4.72
0.02 (0.43%)
At close: Aug 15, 2025, 3:59 PM
4.80
1.59%
After-hours: Aug 15, 2025, 05:16 PM EDT

Organogenesis Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
861K 4.95M 15.53M 94.9M
Depreciation & Amortization
17.03M 23.45M 18.03M 16.68M
Stock-Based Compensation
10.58M 9M 6.55M 3.86M
Other Working Capital
-8.51M -30.08M -19.16M -3.6M
Other Non-Cash Items
45.35M 9.59M 16.85M 17.8M
Deferred Income Tax
-10.72M 2.01M 1.98M -31.98M
Change in Working Capital
-48.89M -18.07M -34.08M -39.29M
Operating Cash Flow
14.21M 30.92M 24.86M 61.98M
Capital Expenditures
-10.03M -24.36M -33.9M -31.22M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-10.03M -24.36M -33.9M -31.22M
Debt Repayment
-67.64M -5.17M -3.01M -2.01M
Common Stock Repurchased
-25.48M n/a n/a n/a
Dividend Paid
-1.8M n/a n/a n/a
Other Financial Acitivies
1.87M -332K -1.26M -1.22M
Financial Cash Flow
27.64M -5.5M -2.2M -1.04M
Net Cash Flow
31.81M 1.05M -11.24M 29.72M
Free Cash Flow
4.18M 6.55M -9.04M 30.76M